{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:36:32Z","timestamp":1793972192760,"version":"4.8.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Uterus transplantation is a temporary transplant allowing women with absolute uterine factor infertility to experience pregnancy and childbirth. The degree of immunosuppression (IS) required to prevent rejection while minimizing toxicity to the recipient and fetus remains an area of investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In this article, we describe immunosuppressive therapy, rejection episodes, infections, and adverse events in 14 uterus transplant recipients. Induction consisted of antithymocyte globulin and methylprednisolone. Ten recipients (71%) received no steroids postoperatively, and 4 (29%) had steroids tapered off at 42 d. All received oral tacrolimus, either immediate release (n = 2, 14%) or extended release (n = 12, 86%). Mycophenolate was used in 4 cases (29%), de novo azathioprine in 9 (64%), and de novo everolimus in 1 (7%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Sixteen clinically silent, treatment-responsive rejection episodes occurred in 10 recipients. Five recipients (36%) experienced acute kidney injury. In 3 recipients, IS was discontinued due to renal dysfunction. Eleven infection episodes were noted in 7 recipients. No babies had congenital abnormalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our experience demonstrates that safe IS regimens can be used for uterus transplant recipients before and during pregnancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004437","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T20:00:22Z","timestamp":1669752022000},"page":"729-736","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Immunosuppression in Uterus Transplantation: Experience From the Dallas Uterus Transplant Study"],"prefix":"10.1097","volume":"107","author":[{"given":"Nicole K.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Transplant, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anji","family":"Wall","sequence":"additional","affiliation":[{"name":"Department of Transplant, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Parrott","sequence":"additional","affiliation":[{"name":"Department of Transplant, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Transplant, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Johannesson","sequence":"additional","affiliation":[{"name":"Department of Transplant, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX."},{"name":"Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Sam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Baylor University Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/ajt.14737","article-title":"First live birth after uterus transplantation in the United States.","volume":"18","author":"Testa","year":"2018","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ajmg.1320260414","article-title":"Vaginal atresia (von Mayer-Rokitansky-K\u00fcster or MRK anomaly) in hereditary renal adysplasia (HRA).","volume":"26","author":"Opitz","year":"1987","journal-title":"Am J Med Genet"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/humrep\/dez126","article-title":"Whole-exome sequencing identifies a GREB1L variant in a three-generation family with M\u00fcllerian and renal agenesis: a novel candidate gene in Mayer-Rokitansky-K\u00fcster-Hauser (MRKH) syndrome. A case report.","volume":"34","author":"Herlin","year":"2019","journal-title":"Hum Reprod"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cge.13769","article-title":"GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer-Rokitansky-Kuster-Hauser syndrome.","volume":"98","author":"Jacquinet","year":"2020","journal-title":"Clin Genet"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000003633","article-title":"Clinicopathological analysis of uterine allografts including proposed scoring of ischemia reperfusion injury and T-cell-mediated rejection\u2014Dallas UtErus Transplant Study: a pilot study.","volume":"106","author":"Agarwal","year":"2022","journal-title":"Transplantation"},{"key":"R6-20250604","first-page":"905","article-title":"Safety of tacrolimus in pregnancy.","volume":"60","author":"Nevers","year":"2014","journal-title":"Can Fam Physician"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jcm7120552","article-title":"Fetal toxicity of immunosuppressive drugs in pregnancy.","volume":"7","author":"Ponticelli","year":"2018","journal-title":"J Clin Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-015-2987-x","article-title":"Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.","volume":"34","author":"Saavedra","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.therap.2017.06.006","article-title":"Pregnancy outcome following in utero exposure to azathioprine: a French comparative observational study.","volume":"73","author":"Alami","year":"2018","journal-title":"Therapie"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.2015.1033404","article-title":"Immunosuppression in pregnant women with systemic lupus erythematosus.","volume":"11","author":"Ponticelli","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ajmg.a.32715","article-title":"Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect.","volume":"149A","author":"Jackson","year":"2009","journal-title":"Am J Med Genet A"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"4539342","DOI":"10.1155\/2016\/4539342","article-title":"Overview of pregnancy in renal transplant patients.","volume":"2016","author":"Shah","year":"2016","journal-title":"Int J Nephrol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1093\/ndt\/gfs276","article-title":"Pregnancy after renal transplantation: a review of registry and single-center practices and outcomes.","volume":"27","author":"Richman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40620-018-0477-3","article-title":"Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.","volume":"31","author":"Colla","year":"2018","journal-title":"J Nephrol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/1471-0528.15863","article-title":"Human uterine transplantation: a review of outcomes from the first 45 cases.","volume":"126","author":"Jones","year":"2019","journal-title":"BJOG"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/TP.0000000000003556","article-title":"The role of patient-reported outcomes and medication adherence assessment in patient-focused drug development for solid organ transplantation.","volume":"105","author":"Karpen","year":"2021","journal-title":"Transplantation"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fertnstert.2014.09.024","article-title":"Uterus transplantation trial: 1-year outcome.","volume":"103","author":"Johannesson","year":"2015","journal-title":"Fertil Steril"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/1471-0528.15860","article-title":"Rethinking the time interval to embryo transfer after uterus transplantation\u2014DUETS (Dallas UtErus Transplant Study).","volume":"126","author":"Johannesson","year":"2019","journal-title":"BJOG"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/SLA.0000000000004199","article-title":"The evolution of transplantation from saving lives to fertility treatment: DUETS (Dallas UtErus Transplant Study).","volume":"272","author":"Testa","year":"2020","journal-title":"Ann Surg"},{"key":"R23-20250604","article-title":"Neonatal outcomes after uterus transplantation: Dallas Uterus Transplant Study.","author":"York","journal-title":"Am J Perinatol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"e13653","DOI":"10.1111\/tid.13653","article-title":"Pregnancy after CMV infection following uterus transplantation: a case report from the Dallas Uterus Transplant Study.","volume":"23","author":"Rosenzweig","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/AOG.0000000000004244","article-title":"Twelve live births after uterus transplantation in the Dallas UtErus Transplant Study.","volume":"137","author":"Johannesson","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/1471-0528.16685","article-title":"Decisions on second pregnancy after uterus transplantation and timing for removal of the uterus\u2014DUETS (Dallas UtErus Transplant Study).","volume":"128","author":"Johannesson","year":"2021","journal-title":"BJOG"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MEG.0000000000002172","article-title":"Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients.","volume":"33","author":"Choi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.clinthera.2013.09.014","article-title":"Treatment satisfaction in renal transplant patients taking tacrolimus once daily.","volume":"35","author":"van Boekel","year":"2013","journal-title":"Clin Ther"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/FTD.0b013e3182708edf","article-title":"Pharmacokinetics of tacrolimus during pregnancy.","volume":"34","author":"Zheng","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ajt.14085","article-title":"Mycophenolate and pregnancy: teratology principles and national transplantation pregnancy registry experience.","volume":"17","author":"Moritz","year":"2017","journal-title":"Am J Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: a newly recognized teratogenic syndrome.","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","article-title":"Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.","volume":"5","author":"McKay","year":"2005","journal-title":"Am J Transplant"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40620-018-0499-x","article-title":"A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology.","volume":"31","author":"Cabiddu","year":"2018","journal-title":"J Nephrol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jmig.2018.11.021","article-title":"Novel anastomotic technique for uterine transplant using utero-ovarian veins for venous drainage and internal iliac arteries for perfusion in two laparoscopically harvested uteri.","volume":"26","author":"Puntambekar","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/ajt.13514","article-title":"First report of a successful pregnancy in an everolimus-treated heart-transplanted patient: neonatal disappearance of immunosuppressive drugs.","volume":"16","author":"Fiocchi","year":"2016","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.transproceed.2013.09.029","article-title":"Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report.","volume":"46","author":"Margoles","year":"2014","journal-title":"Transplant Proc"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2012.05.012","article-title":"Pregnancy in a kidney transplant patient treated with everolimus.","volume":"60","author":"Carta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/TP.0b013e3181ff8754","article-title":"Cause of death with graft function among renal transplant recipients in an integrated healthcare system.","volume":"91","author":"Kahwaji","year":"2011","journal-title":"Transplantation"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e3181fdd96c","article-title":"Increasing trend in infection-related death-censored graft failure in renal transplantation.","volume":"91","author":"Parasuraman","year":"2011","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients.","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1399-3062.2003.00025.x","article-title":"Temporal aspects of transplant infectious disease.","volume":"5","author":"Rubin","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid-organ transplant recipients.","volume":"10","author":"Patel","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 3","key":"R45-20250604","article-title":"A multi-institutional study of renal outcomes in uterus transplantation [abstract].","volume":"21","author":"Sawinski","year":"2021","journal-title":"Am J Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity.","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation.","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/ajt.14911","article-title":"Belatacept during pregnancy in renal transplant recipients: two case reports.","volume":"18","author":"Combs","year":"2018","journal-title":"Am J Transplant"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/tri.13442","article-title":"Allosensitization after transplant failure: the role of graft nephrectomy and immunosuppression \u2013 a retrospective study.","volume":"32","author":"Lucisano","year":"2019","journal-title":"Transpl Int"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/ctr.12743","article-title":"Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.","volume":"30","author":"Matignon","year":"2016","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:21:11Z","timestamp":1749061271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004437","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}